Your browser doesn't support javascript.
loading
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.
Bellusci, Lorenza; Grubbs, Gabrielle; Zahra, Fatema Tuz; Forgacs, David; Golding, Hana; Ross, Ted M; Khurana, Surender.
Afiliación
  • Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20871, USA.
  • Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20871, USA.
  • Zahra FT; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20871, USA.
  • Forgacs D; Center for Vaccines and Immunology, University of Georgia, Athens, GA, 30602, USA.
  • Golding H; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, 20871, USA.
  • Ross TM; Center for Vaccines and Immunology, University of Georgia, Athens, GA, 30602, USA.
  • Khurana S; Department of Infectious Diseases, University of Georgia, Athens, GA, 30602, USA.
Nat Commun ; 13(1): 4617, 2022 08 08.
Article en En | MEDLINE | ID: mdl-35941152
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Adult / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Adult / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos